Clinigen notes results from the MIROCALS trial investigating low dose Proleukin (aldesleukin) in patients with amyotrophic lateral sclerosis
8 December 2022 Clinigen notes results from the MIROCALS trial investigating low dose Proleukin (aldesleukin) in patients with amyotrophic lateral sclerosis Clinigen Limited